The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Local tumour hyperthermia as immunotherapy for metastatic cancer
Open accessAbstract
Abstract Local tumour hyperthermia for cancer treatment is currently used either for ablation purposes as an alternative to surgery or less frequently, in combination with chemotherapy and/or radiation therapy to enhance the effects of those traditional therapies. As it has become apparent that activating the immune system is crucial to successfully treat metastatic cancer, the potential of boosting anti-tumour immunity by heating tumours has become a growing area of cancer research. After reviewing the history of hyperthermia therapy for cancer and introducing methods for inducing local hyperthermia, this review describes different mechanisms by which heating tumours can elicit anti-tumour immune responses, including tumour cell damage, tumour surface molecule changes, heat shock proteins, exosomes, direct effects on immune cells, and changes in the tumour vasculature. We then go over in vivo studies that provide promising results showing that local hyperthermia therapy indeed activates various systemic anti-tumour immune responses that slow growth of untreated tumours. Finally, future research questions that will help bring the use of local hyperthermia as systemic immunotherapy closer to clinical application are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exosomes: composition, biogenesis and function
Théry, C., Zitvogel, L., & Amigorena, S. (2002) · Nature Reviews Immunology · doi:10.1038/nri855 · Cited by 5,346
Thermal dose determination in cancer therapy
Sapareto, S. A., & Dewey, W. C. (1984) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(84)90379-1 · Cited by 2,498
Hyperthermia in combined treatment of cancer
Wust, P., Hildebrandt, B., Sreenivasa, G., Rau, B., Gellermann, J., Riess, H., Felix, R., & Schlag, P. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00818-5 · Cited by 1,998
The cellular and molecular basis of hyperthermia
Hildebrandt, B. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00179-2 · Cited by 1,718
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Théry, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., et al. (2001) · Nature Medicine · doi:10.1038/85438 · Cited by 1,640
Novel Signal Transduction Pathway Utilized by Extracellular HSP70
Asea, A., Rehli, M., Kabingu, E., Boch, J. A., Baré, O., Auron, P. E., Stevenson, M. A., & Calderwood, S. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200497200 · Cited by 1,510
Heating the patient: a promising approach?
van der Zee, J. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf280 · Cited by 1,220
Immunogenic and tolerogenic cell death
Green, D. R., Ferguson, T., Zitvogel, L., & Kroemer, G. (2009) · Nature Reviews Immunology · doi:10.1038/nri2545 · Cited by 1,176
Hypoxic enhancement of exosome release by breast cancer cells
King, H. W., Michael, M. Z., & Gleadle, J. M. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-421 · Cited by 1,045
Malignant effusions and immunogenic tumour-derived exosomes
Andre, F., Schartz, N. E., Movassagh, M., Flament, C., Pautier, P., Morice, P., Pomel, C., Lhomme, C., Escudier, B., Le Chevalier, T., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09552-1 · Cited by 953
HSP70 as Endogenous Stimulus of the Toll/Interleukin-1 Receptor Signal Pathway
Vabulas, R. M., Ahmad-Nejad, P., Ghose, S., Kirschning, C. J., Issels, R. D., & Wagner, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111204200 · Cited by 948
Mitchem, J. B., Brennan, D. J., Knolhoff, B. L., Belt, B. A., Zhu, Y., Sanford, D. E., Belaygorod, L., Carpenter, D., Collins, L., Piwnica-Worms, D., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2731 · Cited by 943
A Mechanism for the Specific Immunogenicity of Heat Shock Protein-Chaperoned Peptides
Suto, R., & Srivastava, P. K. (1995) · Science · doi:10.1126/science.7545313 · Cited by 823
Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles
Andreola, G., Rivoltini, L., Castelli, C., Huber, V., Perego, P., Deho, P., Squarcina, P., Accornero, P., Lozupone, F., Lugini, L., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011624 · Cited by 774
Hsp90 inhibitors as novel cancer chemotherapeutic agents
Neckers, L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02316-x · Cited by 677
de Jong, O. G., Verhaar, M. C., Chen, Y., Vader, P., Gremmels, H., Posthuma, G., Schiffelers, R. M., Gucek, M., & van Balkom, B. W. M. (2012) · Journal of Extracellular Vesicles · doi:10.3402/jev.v1i0.18396 · Cited by 634
Huber, V., Fais, S., Iero, M., Lugini, L., Canese, P., Squarcina, P., Zaccheddu, A., Colone, M., Arancia, G., Gentile, M., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.045 · Cited by 524
Human Tumor-Derived Exosomes Selectively Impair Lymphocyte Responses to Interleukin-2
Clayton, A., Mitchell, J. P., Court, J., Mason, M. D., & Tabi, Z. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3456 · Cited by 520
Valenti, R., Huber, V., Filipazzi, P., Pilla, L., Sovena, G., Villa, A., Corbelli, A., Fais, S., Parmiani, G., & Rivoltini, L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1819 · Cited by 493
Heat shock proteins as cellular lifeguards
Jäättelä, M. (1999) · Annals of Medicine · doi:10.3109/07853899908995889 · Cited by 486
Coley's toxins, tumor necrosis factor and cancer research: A historical perspective
Wiemann, B., & Starnes, C. O. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90023-x · Cited by 467
Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature.
Kong, G., Braun, R. D., & Dewhirst, M. W. (2001) · PubMed · Cited by 442
In Situ Tumor Ablation Creates an Antigen Source for the Generation of Antitumor Immunity
den Brok, M. H. M. G. M., Sutmuller, R. P. M., van der Voort, R., Bennink, E. J., Figdor, C. G., Ruers, T. J. M., & Adema, G. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3949 · Cited by 426
Cellular effects of hyperthermia: relevance to the minimum dose for thermal damage
Lepock, J. R. (2003) · International Journal of Hyperthermia · doi:10.1080/0265673031000065042 · Cited by 395
Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
Fucikova, J., Kralikova, P., Fialova, A., Brtnicky, T., Rob, L., Bartunkova, J., & Špíšek, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0950 · Cited by 392
Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells
Multhoff, G., Botzler, C., Jennen, L., Schmidt, J., Ellwart, J., & Issels, R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4341 · Cited by 387
Schiavoni, G., Sistigu, A., Valentini, M., Mattei, F., Sestili, P., Spadaro, F., Sanchez, M., Lorenzi, S., D'Urso, M. T., Belardelli, F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2788 · Cited by 362
Udono, H., Levey, D. L., & Srivastava, P. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3077 · Cited by 347
Todryk, S., Melcher, A. A., Hardwick, N., Linardakis, E., Bateman, A., Colombo, M. P., Stoppacciaro, A., & Vile, R. G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1398 · Cited by 328
Binder, R. J., & Srivastava, P. K. (2005) · Nature Immunology · doi:10.1038/ni1201 · Cited by 295
Wust, >., Gneveckow, U., Wust, >., Gneveckow, U., Johannsen, M., Böhmer, D., Henkel, T., Kahmann, F., Sehouli, J., Felix, R., et al. (2006) · International Journal of Hyperthermia · doi:10.1080/02656730601106037 · Cited by 294
Tumor-Derived Heat Shock Protein 70 Peptide Complexes Are Cross-Presented by Human Dendritic Cells
Noessner, E., Gastpar, R., Milani, V., Brandl, A., Hutzler, P. J. S., Kuppner, M. C., Roos, M., Kremmer, E., Asea, A., Calderwood, S. K., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5424 · Cited by 262
Old and new facts about hyperthermia-induced modulations of the immune system
Frey, B., Weiss, E.-M., Rubner, Y., Wunderlich, R., Ott, O. J., Sauer, R., Fietkau, R., & Gaipl, U. S. (2012) · International Journal of Hyperthermia · doi:10.3109/02656736.2012.677933 · Cited by 252
Suzue, K., Zhou, X., Eisen, H. N., & Young, R. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13146 · Cited by 250
Chen, T., Guo, J., Han, C., Yang, M., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1449 · Cited by 236
Fisher, D. T., Chen, Q., Skitzki, J. J., Muhitch, J. B., Zhou, L., Appenheimer, M. M., Vardam, T. D., Weis, E. L., Passanese, J., Wang, W.-C., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44952 · Cited by 229
Chen, T., Guo, J., Yang, M., Zhu, X., & Cao, X. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002991 · Cited by 227
Multhoff, G., Mizzen, L., Winchester, C. C., Milner, C. M., Wenk, S., Eissner, G., Kampinga, H. H., Laumbacher, B., & Johnson, J. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00104-6 · Cited by 223
Ito, A., Tanaka, K., Kondo, K., Shinkai, M., Honda, H., Matsumoto, K., Saida, T., & Kobayashi, T. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01438.x · Cited by 216
Ecto‐calreticulin in immunogenic chemotherapy
Obeid, M., Tesniere, A., Panaretakis, T., Tufi, R., Joza, N., Van Endert, P., Ghiringhelli, F., Apetoh, L., Chaput, N., Flament, C., et al. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00567.x · Cited by 202 · cited 14×
“While many HSPs are considered generally immunostimulatory [40,41,43,48,49] and hence would help suppress tumour growth, negative roles of some HSPs in suppressing tumour growth are also reported [50–53].”
BackgroundInfluentialDai, S., Wan, T., Wang, B., Zhou, X., Xiu, F., Chen, T., Wu, Y., & Cao, X. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0810 · Cited by 199
Toraya-Brown, S., Sheen, M. R., Zhang, P., Chen, L., Baird, J. R., Demidenko, E., Turk, M. J., Hoopes, P. J., Conejo-Garcia, J. R., & Fiering, S. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.01.011 · Cited by 193
Self-citationAntitumor Immunity Induction by Intracellular Hyperthermia Using Magnetite Cationic Liposomes
Yanase, M., Shinkai, M., Honda, H., Wakabayashi, T., Yoshida, J., & Kobayashi, T. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb03283.x · Cited by 181
Combination immunotherapy approaches
Drake, C. G. (2012) · Annals of Oncology · doi:10.1093/annonc/mds262 · Cited by 168
Bethke, K., Staib, F., Distler, M., Schmitt, U., Jonuleit, H., Enk, A. H., Galle, P. R., & Heike, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6141 · Cited by 165
Bear, A. S., Kennedy, L. C., Young, J. K., Perna, S. K., Mattos Almeida, J. P., Lin, A. Y., Eckels, P. C., Drezek, R. A., & Foster, A. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069073 · Cited by 163
Nanoparticle-mediated thermal therapy: Evolving strategies for prostate cancer therapy
Krishnan, S., Diagaradjane, P., & Cho, S. H. (2010) · International Journal of Hyperthermia · doi:10.3109/02656736.2010.485593 · Cited by 160
Exosomes and the MICA-NKG2D system in cancer
Clayton, A., & Tabi, Z. (2005) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.03.003 · Cited by 149
Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma
Bu, N., Wu, H., Sun, B.-Z., Zhang, G., Zhan, S., Zhang, R., & Zhou, L. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0537-1 · Cited by 140
Ostberg, J. R., Dayanç, B. E., Yuan, M., Oflazoglu, E., & Repasky, E. A. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1106699 · Cited by 138
Definition of extracellular localized epitopes of Hsp70 involved in an NK immune response
Botzler, C., Li, G. C., Issels, R. D., & Multhoff, G. (1998) · Cell Stress and Chaperones · Cited by 128
Tanaka, K., Itô, A., Kobayashi, T., Kawamura, T., Shimada, S., Matsumoto, K., Saida, T., & Honda, H. (2005) · International Journal of Cancer · doi:10.1002/ijc.21061 · Cited by 123
Effector CD8 + T cell IFN- γ production and cytotoxicity are enhanced by mild hyperthermia
Mace, T. A., Zhong, L., Kokolus, K. M., & Repasky, E. A. (2012) · International Journal of Hyperthermia · doi:10.3109/02656736.2011.616182 · Cited by 105
Suzuki, M., Shinkai, M., Honda, H., & Kobayashi, T. (2003) · Melanoma Research · doi:10.1097/00008390-200304000-00004 · Cited by 103
Breloer, M., Dorner, B. G., Moré, S. H., Roderian, T., Fleischer, B., & von Bonin, A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200107)31:7<2051::aid-immu2051>3.0.co;2-h · Cited by 100
Ostberg, J. R., & Repasky, E. A. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0689-y · Cited by 91
Lin, K., Rockliffe, N., Johnson, G. G., Sherrington, P. D., & Pettitt, A. R. (2007) · Oncogene · doi:10.1038/sj.onc.1210893 · Cited by 91
Huntoon, C. J., Nye, M. D., Geng, L., Peterson, K. L., Flatten, K. S., Haluska, P., Kaufmann, S. H., & Karnitz, L. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1345 · Cited by 77
Cw, S., Shakil, A., Griffin, R. J., & Okajima, K. (1997) · PubMed · Cited by 71
Stevenson, M. A., Calderwood, S. K., & Hahn, G. M. (1987) · PubMed · Cited by 65
Partanen, A., Tillander, M., Yarmolenko, P., Wood, B. J., Dreher, M. R., & Köhler, M. O. (2012) · Medical Physics · doi:10.1118/1.4769116 · Cited by 53
Petryk, A. A., Giustini, A. J., Gottesman, R. E., Trembly, B. S., & Hoopes, P. J. (2013) · International Journal of Hyperthermia · doi:10.3109/02656736.2013.845801 · Cited by 51
van Bruggen, I., Robertson, T. A., & Papadimitriou, J. M. (1991) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(91)90047-2 · Cited by 44
Qian, J., Yi, H., Guo, C., Yu, X., Zuo, D., Chen, X., Kane, J. M., Repasky, E. A., Subjeck, J. R., & Wang, X. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100703 · Cited by 37
Nitric oxide production is regulated by fever-range thermal stimulation of murine macrophages
Pritchard, M. T., Li, Z., & Repasky, E. A. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0404220 · Cited by 35
Zheng, H., Benjamin, I. J., Basu, S., & Li, Z. (2003) · European Journal of Immunology · doi:10.1002/eji.200323687 · Cited by 34
Nishida, T., Akagi, K., & Tanaka, Y. (1997) · International Journal of Hyperthermia · doi:10.3109/02656739709012385 · Cited by 29
Mitoxantrone-Mediated Apoptotic B16-F1 Cells Induce Specific Anti-tumor Immune Response
Cao, C., Yu, H., Ren, Y., & Wang, Y. (2009) · Cellular and Molecular Immunology · doi:10.1038/cmi.2009.59 · Cited by 29
Meyer, R. E., Braun, R. D., Rosner, G., & Dewhirst, M. W. (2000) · Radiation Research · doi:10.1667/0033-7587(2000)154[0196:lchivc]2.0.co;2 · Cited by 19
Cited by
Datta, N. R., Ordóñez, S. G., Gaipl, U. S., Paulides, M. M., Crezee, H., Gellermann, J., Marder, D., Puric, E., & Bodis, S. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.05.009 · Cited by 588
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
Ye, F., Dewanjee, S., Li, Y., Jha, N. K., Chen, Z.-S., Kumar, A., Vishakha, Behl, T., Jha, S. K., & Tang, H. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01805-y · Cited by 554
Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis
Reiter, R., Rosales-Corral, S., Tan, D.-X., Acuna-Castroviejo, D., Qin, L., Yang, S.-F., & Xu, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040843 · Cited by 433
Mahmoudi, K., Bouras, A., Bozec, D., Ivkov, R., & Hadjipanayis, C. (2018) · International Journal of Hyperthermia · doi:10.1080/02656736.2018.1430867 · Cited by 414
Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies
Soetaert, F., Korangath, P., Serantes, D., Fiering, S., & Ivkov, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.025 · Cited by 406
Self-citation
Metadata
- Authors
- Toraya-Brown, S., & Fiering, S.
- Venue
- International Journal of Hyperthermia
- Publisher
- Informa UK Limited
- Published
- 2014-11-28
- Volume
- 30
- Issue
- 8
- Pages
- 531-539
- ISSN
- 0265-6736 (ISSN-L)
- 1464-5157
- OpenAlex
- W2031696462
- Cited by
- 302
- References
- 70
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.